Molecular insights into the structure-function relationship of organic anion transporters OATs

Pharmaceutical Research

Volumn 24, Issue 1, 2007, Pages 28-36

  Zhou, Fanfan ^a,b   You, Guofeng ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Drug transporter; Structure function relationship

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MEMBRANE PROTEIN; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; ORGANIC ANION TRANSPORTER 5; ORGANIC ANION TRANSPORTER 6; PROTEIN URAT1; TOXIN;

BODY REGIONS; CELL SURFACE; ENVIRONMENTAL FACTOR; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SURVIVAL;

ANIMALS; HUMANS; MICE; MICE, KNOCKOUT; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, GENETIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33845446759     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9144-9     Document Type: Review

References (98)

1. G. You. The role of organic ion transporters in drug disposition: an update. Curr. Drug Metab. 5:55-62 (2004).
2. G. You. Structure, function, and regulation of renal organic anion transporters. Med. Res. Rev. 22:602-616 (2002).
3. G. You. Towards an understanding of organic anion transporters: structure-function relationships. Med. Res. Rev. 24:762-774 (2004).
4. T. Sekine, H. Miyazaki, and H. Endou. Molecular physiology of renal organic anion transporters. Am. J. Physiol. Renal. Physiol. 290:F251-F261 (2006).
5. B. C. Burckhardt and G. Burckhardt. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev. Physiol. Biochem. Pharmacol. 146:95-158 (2003).
6. D. H. Sweet. Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol. Appl. Pharmacol. 204:198-215 (2005).
7. S. A. Eraly, K. T. Bush, R. V. Sampogna, V. Bhatnagar, and S. K. Nigam. The molecular pharmacology of organic anion transporters: from DNA to FDA?. Mol. Pharmacol. 65:479-487 (2004).
8. M. J. Dresser, M. K. Leabman, and K. M. Giacomini. Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J. Pharm. Sci. 90:397-421 (2001).
9. H. Miyazaki, T. Sekine, and H. Endou. The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol. Sci. 25:654-662 (2004).
10. T. Sekine, S. H. Cha, and H. Endou. The multispecific organic anion transporter (OAT) family. Pflugers Arch. 440:337-350 (2000).
11. C. E. Lopez-Nieto, G. You, K. T. Bush, E. J. Barros, D. R. Beier, and S. K. Nigam. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J. Biol. Chem. 272:6471-6478 (1997).
12. T. Sekine, N. Watanabe, M. Hosoyamada, Y. Kanai, and H. Endou. Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272:18526-18529 (1997).
13. D. H. Sweet, N. A. Wolff, and J. B. Pritchard. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J. Biol. Chem. 272:30088-30095 (1997).
14. N. A. Wolff, A. Werner, S. Burkhardt, and G. Burckhardt. Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett. 417:287-291 (1997).
15. S. H. Cha, T. Sekine, J. I. Fukushima, Y. Kanai, Y. Kobayashi, T. Goya, and H. Endou. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol. 59:1277-1286 (2001).
16. T. Cihlar, D. C. Lin, J. B. Pritchard, M. D. Fuller, D. B. Mendel, and D. H. Sweet. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol. Pharmacol. 56:570-580 (1999).
17. M. Hosoyamada, T. Sekine, Y. Kanai, and H. Endou. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am. J. Physiol. 276:F122-F128 (1999).
18. R. Kojima, T. Sekine, M. Kawachi, S. H. Cha, Y. Suzuki, and H. Endou. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J. Am. Soc. Nephrol. 13:848-857 (2002).
19. H. Kusuhara, T. Sekine, N. Utsunomiya-Tate, M. Tsuda, R. Kojima, S. H. Cha, Y. Sugiyama, Y. Kanai, and H. Endou. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J. Biol. Chem. 274:13675-13680 (1999).
20. R. Lu, B. S. Chan, and V. L. Schuster. Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am. J. Physiol. 276:F295-F303 (1999).
21. H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa, and K. Inui. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol. 13:866-874 (2002).
22. J. E. Race, S. M. Grassl, W. J. Williams, and E. J. Holtzman. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem. Biophys. Res. Commun. 255:508-514 (1999).
23. H. Tahara, M. Shono, H. Kusuhara, H. Kinoshita, E. Fuse, A. Takadate, M. Otagiri, and Y. Sugiyama. Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm. Res. 22:647-660 (2005).
24. A. Tojo, T. Sekine, N. Nakajima, M. Hosoyamada, Y. Kanai, K. Kimura, and H. Endou. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J. Am. Soc. Nephrol. 10:464-471 (1999).
25. M. Alebouyeh, M. Takeda, M. L. Onozato, A. Tojo, R. Noshiro, H. Hasannejad, J. Inatomi, S. Narikawa, X. L. Huang, S. Khamdang, N. Anzai, and H. Endou. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J. Pharmacol. Sci. 93:430-436 (2003).
26. D. H. Sweet, L. M. Chan, R. Walden, X. P. Yang, D. S. Miller, and J. B. Pritchard. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. Am. J. Physiol. Renal. Physiol. 284:F763-F769 (2003).
27. A. Enomoto, M. Takeda, M. Shimoda, S. Narikawa, Y. Kobayashi, Y. Kobayashi, T. Yamamoto, T. Sekine, S. H. Cha, T. Niwa, and H. Endou. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J. Pharmacol. Exp. Ther. 301:797-802 (2002).
28. Y. Kobayashi, N. Ohshiro, A. Shibusawa, T. Sasaki, S. Tokuyama, T. Sekine, H. Endou, and T. Yamamoto. Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol. Pharmacol. 62:7-14 (2002).
29. T. Sekine, S. H. Cha, M. Tsuda, N. Apiwattanakul, N. Nakajima, Y. Kanai, and H. Endou. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 429:179-182 (1998).
30. G. D. Simonson, A. C. Vincent, K. J. Roberg, Y. Huang, and V. Iwanij. Molecular cloning and characterization of a novel liver-specific transport protein. J. Cell. Sci. 107Pt4): 1065-1072 (1994).
31. Y. Kobayashi, N. Ohshiro, R. Sakai, M. Ohbayashi, N. Kohyama, and T. Yamamoto. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). J. Pharm. Pharmacol. 57:573-578 (2005).
32. S. H. Cha, T. Sekine, H. Kusuhara, E. Yu, J. Y. Kim, D. K. Kim, Y. Sugiyama, Y. Kanai, and H. Endou. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem. 275:4507-4512 (2000).
33. S. Ekaratanawong, N. Anzai, P. Jutabha, H. Miyazaki, R. Noshiro, M. Takeda, Y. Kanai, S. Sophasan, and H. Endou. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J. Pharmacol. Sci. 94:297-304 (2004).
34. N. Anzai, P. Jutabha, A. Enomoto, H. Yokoyama, H. Nonoguchi, T. Hirata, K. Shiraya, X. He, S. H. Cha, M. Takeda, H. Miyazaki, T. Sakata, K. Tomita, T. Igarashi, Y. Kanai, and H. Endou. Functional characterization of rat organic anion transporter 5 (slc22a19) at the apical membrane of renal proximal tubules. J. Pharmacol. Exp. Ther. 315:534-544 (2005).
35. J. O. Kwak, H. W. Kim, K. J. Oh, C. B. Ko, H. Park, and S. H. Cha. Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter. J. Steroid Biochem. Mol. Biol. 97:369-375 (2005).
36. G. L. Youngblood and D. H. Sweet. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am. J. Physiol. Renal. Physiol. 287:F236-F244 (2004).
37. J. C. Monte, M. A. Nagle, S. A. Eraly, and S. K. Nigam. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem. Biophys. Res. Commun. 323:429-436 (2004).
38. G. W. Schnabolk, G. L. Youngblood, and D. H. Sweet. Transport of Estrone Sulfate by the novel organic anion transporter OAT6 (Slc22a20). Am. J. Physiol. Renal. Physiol. 291:F314-F321 (2006).
39. A. Enomoto, H. Kimura, A. Chairoungdua, Y. Shigeta, P. Jutabha, S. H. Cha, M. Hosoyamada, M. Takeda, T. Sekine, T. Igarashi, H. Matsuo, Y. Kikuchi, T. Oda, K. Ichida, T. Hosoya, K. Shimokata, T. Niwa, Y. Kanai, and H. Endou. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-452 (2002).
40. G. You, K. Kuze, R. A. Kohanski, K. Amsler, and S. Henderson. Regulation of mOAT-mediated organic anion transport by okadaic acid and protein kinase C in LLC-PK(1) cells. J. Biol. Chem. 275:10278-10284 (2000).
41. S. Soodvilai, V. Chatsudthipong, K. K. Evans, S. H. Wright, and W. H. Dantzler. Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am. J. Physiol. Renal. Physiol. 287:F1021-F1029 (2004).
42. Y. Uwai, M. Okuda, K. Takami, Y. Hashimoto, and K. Inui. Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett. 438:321-324 (1998).
43. N. A. Wolff, K. Thies, N. Kuhnke, G. Reid, B. Friedrich, F. Lang, and G. Burckhardt. Protein kinase C activation down-regulates human organic anion transporter 1-mediated transport through carrier internalization. J. Am. Soc. Nephrol. 14:1959-1968 (2003).
44. F. Zhou, N. P. Illsley, and G. You. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. Eur. J. Pharm. Sci. 275): 518-523 (2006).
45. D. Hesse, C. Sauvant, H. Holzinger, and M. Gekle. Apical expression or expression in a non polarized cell of hOAT1 inverses regulation by epidermal growth factor (EGF) as compared to basolateral hOAT1. Cell. Physiol. Biochem. 14:177-186 (2004).
46. C. Sauvant, D. Hesse, H. Holzinger, K. K. Evans, W. H. Dantzler, and M. Gekle. Action of EGF and PGE2 on basolateral organic anion uptake in rabbit proximal renal tubules and hOAT1 expressed in human kidney epithelial cells. Am. J. Physiol. Renal. Physiol. 286:F774-F783 (2004).
47. S. Soodvilai, S. H. Wright, W. H. Dantzler, and V. Chatsudthipong. Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am. J. Physiol. Renal. Physiol. 289:F1057-F1064 (2005).
48. J. Abramson, I. Smirnova, V. Kasho, G. Verner, H. R. Kaback, and S. Iwata. Structure and mechanism of the lactose permease of Escherichia coli. Science 301:610-615 (2003).
49. Y. Huang, M. J. Lemieux, J. Song, M. Auer, and D. N. Wang. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301:616-620 (2003).
50. C. Popp, V. Gorboulev, T. D. Muller, D. Gorbunov, N. Shatskaya, and H. Koepsell. Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol. Pharmacol. 67:1600-1611 (2005).
51. X. Zhang, N. V. Shirahatti, D. Mahadevan, and S. H. Wright. A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2). J. Biol. Chem. 280:34813-34822 (2005).
52. K. Tanaka, W. Xu, F. Zhou, and G. You. Role of glycosylation in the organic anion transporter OAT1. J. Biol. Chem. 279:14961-14966 (2004).
53. F. Zhou, W. Xu, M. Hong, Z. Pan, P. J. Sinko, J. Ma, and G. You. The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol. Pharmacol. 67:868-876 (2005).
54. J. C. de Jong, P. H. Willems, F. J. Mooren, L. P. van den Heuvel, N. V. Knoers, and R. J. Bindels. The structural unit of the thiazide-sensitive NaCl cotransporter is a homodimer. J. Biol. Chem. 278:24302-24307 (2003).
55. F. Kilic and G. Rudnick. Oligomerization of serotonin transporter and its functional consequences. Proc. Natl. Acad. Sci. U. S. A. 97:3106-3111 (2000).
56. J. Xu, Y. Liu, Y. Yang, S. Bates, and J. T. Zhang. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J. Biol. Chem. 279:19781-19789 (2004).
57. M. Hong, W. Xu, T. Yoshida, K. Tanaka, D. J. Wolff, F. Zhou, M. Inouye, and G. You. Human organic anion transporter hOAT1 forms homooligomers. J. Biol. Chem. 280:32285-32290 (2005).
58. G. M. Preston, J. S. Jung, W. B. Guggino, and P. Agre. The mercury-sensitive residue at cysteine 189 in the CHIP28 water channel. J. Biol. Chem. 268:17-20 (1993).
59. R. MacKinnon. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 350:232-235 (1991).
60. H. H. Sitte, H. Farhan, and J. A. Javitch. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Interv. 4:38-47 (2004).
61. P. Scholze, M. Freissmuth, and H. H. Sitte. Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J. Biol. Chem. 277:43682-43690 (2002).
62. P. Burkhard, J. Stetefeld, and S. V. Strelkov. Coiled coils: a highly versatile protein folding motif. Trends Cell Biol. 11:82-88 (2001).
63. P. Zhang, A. McAlinden, S. Li, T. Schumacher, H. Wang, S. Hu, L. Sandell, and E. Crouch. The amino-terminal heptad repeats of the coiled-coil neck domain of pulmonary surfactant protein d are necessary for the assembly of trimeric subunits and dodecamers. J. Biol. Chem. 276:19862-19870 (2001).
64. R. Li, R. Gorelik, V. Nanda, P. B. Law, J. D. Lear, W. F. DeGrado, and J. S. Bennett. Dimerization of the transmembrane domain of Integrin alphaIIb subunit in cell membranes. J. Biol. Chem. 279:26666-26673 (2004).
65. W. P. Russ and D. M. Engelman. The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 296:911-919 (2000).
66. C. B. Dugani and A. Klip. Glucose transporter 4: cycling, compartments and controversies. EMBO Rep. 6:1137-1142 (2005).
67. T. R. Muth and M. J. Caplan. Transport protein trafficking in polarized cells. Annu. Rev. Cell Dev. Biol. 19:333-366 (2003).
68. P. D. Wilson, A. C. Sherwood, K. Palla, J. Du, R. Watson, and J. T. Norman. Reversed polarity of Na(+) -K(+) - ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia. Am. J. Physiol. 260:F420-F430 (1991).
69. J. Biber, S. M. Gisler, N. Hernando, and H. Murer. Protein/protein interactions (PDZ) in proximal tubules. J. Membr. Biol. 203:111-118 (2005).
70. Y. Kato, C. Watanabe, and A. Tsuji. Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors. Eur. J. Pharm. Sci. 27:487-500 (2006).
71. C. Perego, C. Vanoni, A. Villa, R. Longhi, S. M. Kaech, E. Frohli, A. Hajnal, S. K. Kim, and G. Pietrini. PDZ-mediated interactions retain the epithelial GABA transporter on the basolateral surface of polarized epithelial cells. Embo J. 18:2384-2393 (1999).
72. V. Raghuram, H. Hormuth, and J. K. Foskett. A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions. Proc. Natl. Acad. Sci. U. S. A. 100:9620-9625 (2003).
73. S. Shenolikar, J. W. Voltz, C. M. Minkoff, J. B. Wade, and E. J. Weinman. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc. Natl. Acad. Sci. U. S. A. 99:11470-11475 (2002).
74. N. Anzai, H. Miyazaki, R. Noshiro, S. Khamdang, A. Chairoungdua, H. J. Shin, A. Enomoto, S. Sakamoto, T. Hirata, K. Tomita, Y. Kanai, and H. Endou. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J. Biol. Chem. 279:45942-45950 (2004).
75. H. Miyazaki, N. Anzai, S. Ekaratanawong, T. Sakata, H. J. Shin, P. Jutabha, T. Hirata, X. He, H. Nonoguchi, K. Tomita, Y. Kanai, and H. Endou. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J. Am. Soc. Nephrol. 16:3498-3506 (2005).
76. C. Schwencke, R. C. Braun-Dullaeus, C. Wunderlich, and R. H. Strasser. Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc. Res. 70:42-49 (2006).
77. J. O. Kwak, H. W. Kim, K. J. Oh, D. S. Kim, K. O. Han, and S. H. Cha. Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney. Exp. Mol. Med. 37:204-212 (2005).
78. J. O. Kwak, H. W. Kim, J. H. Song, M. J. Kim, H. S. Park, D. K. Hyun, D. S. Kim, and S. H. Cha. Evidence for rat organic anion transporter 3 association with caveolin-1 in rat kidney. IUBMB Life 57:109-117 (2005).
79. S. A. Eraly, V. Vallon, D. A. Vaughn, J. A. Gangoiti, K. Richter, M. Nagle, J. C. Monte, T. Rieg, D. M. Truong, J. M. Long, B. A. Barshop, G. Kaler, and S. K. Nigam. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knockout mice. J. Biol. Chem. 2818): 5072-5083 (2006).
80. D. H. Sweet, D. S. Miller, J. B. Pritchard, Y. Fujiwara, D. R. Beier, and S. K. Nigam. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J. Biol. Chem. 277:26934-26943 (2002).
81. G. Reid, N. A. Wolff, F. M. Dautzenberg, and G. Burckhardt. Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press. Res. 21:233-237 (1998).
82. W. Sun, R. R. Wu, P. D. van Poelje, and M. D. Erion. Isolation of a family of organic anion transporters from human liver and kidney. Biochem. Biophys. Res. Commun. 283:417-422 (2001).
83. A. R. Asif, J. Steffgen, M. Metten, R. W. Grunewald, G. A. Muller, A. Bahn, G. Burckhardt, and Y. Hagos. Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells. Pflugers Arch. 450:88-95 (2005).
84. E. Babu, M. Takeda, S. Narikawa, Y. Kobayashi, A. Enomoto, A. Tojo, S. H. Cha, T. Sekine, D. Sakthisekaran, and H. Endou. Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim. Biophys. Acta 1590:64-75 (2002).
85. M. Hong, F. Zhou, and G. You. Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1. J. Biol. Chem. 279:31478-31482 (2004).
86. K. Tanaka, F. Zhou, K. Kuze, and G. You. Cysteine residues in the organic anion transporter mOAT1. Biochem. J. 380:283-287 (2004).
87. N. A. Wolff, B. Grunwald, B. Friedrich, F. Lang, S. Godehardt, and G. Burckhardt. Cationic amino acids involved in dicarboxylate binding of the flounder renal organic anion transporter. J. Am. Soc. Nephrol. 12:2012-2018 (2001).
88. B. Feng, M. J. Dresser, Y. Shu, S. J. Johns, and K. M. Giacomini. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry 40:5511-5520 (2001).
89. B. Feng, Y. Shu, and K. M. Giacomini. Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in substrate recognition. Biochemistry 41:8941-8947 (2002).
90. F. Zhou, K. Tanaka, Z. Pan, J. Ma, and G. You. The role of glycine residues in the function of human organic anion transporter 4. Mol. Pharmacol. 65:1141-1147 (2004).
91. F. Zhou, Z. Pan, J. Ma, and G. You. Mutational analysis of histidine residues in human organic anion transporter 4 (hOAT4). Biochem. J. 384:87-92 (2004).
92. K. Bleasby, L. A. Hall, J. L. Perry, H. W. Mohrenweiser, and J. B. Pritchard. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J. Pharmacol. Exp. Ther. 314:923-931 (2005).
93. G. Xu, V. Bhatnagar, G. Wen, B. A. Hamilton, S. A. Eraly, and S. K. Nigam. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int. 68:1491-1499 (2005).
94. A. R. Erdman, L. M. Mangravite, T. J. Urban, L. L. Lagpacan, R. A. Castro, M. Cruzde la, W. Chan, C. C. Huang, S. J. Johns, M. Kawamoto, D. Stryke, T. R. Taylor, E. J. Carlson, T. E. Ferrin, C. M. Brett, E. G. Burchard, and K. M. Giacomini. Giacomini. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am. J. Physiol. Renal Physiol. 2904): F905-F912 (2006).
95. Y. Nishizato, I. Ieiri, H. Suzuki, M. Kimura, K. Kawabata, T. Hirota, H. Takane, S. Irie, H. Kusuhara, Y. Urasaki, A. Urae, S. Higuchi, K. Otsubo, and Y. Sugiyama. Polymorphisms of OATPC (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharmacol. Ther. 73:554-565 (2003).
96. H. I. Cheong, J. H. Kang, J. H. Lee, I. S. Ha, S. Kim, F. Komoda, T. Sekine, T. Igarashi, and Y. Choi. Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr. Nephrol. 20:886-890 (2005).
97. K. Ichida, M. Hosoyamada, I. Hisatome, A. Enomoto, M. Hikita, H. Endou, and T. Hosoya. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 15:164-173 (2004).
98. F. Komoda, T. Sekine, J. Inatomi, A. Enomoto, H. Endou, T. Ota, T. Matsuyama, T. Ogata, M. Ikeda, M. Awazu, K. Muroya, I. Kamimaki, and T. Igarashi. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr. Nephrol. 19:728-733 (2004).